About RemedyBio
RemedyBio is a company based in Dublin (Ireland) founded in 2017. RemedyBio has raised $9.43 million across 4 funding rounds from investors including Enterprise Ireland, European Union and Dublin City University. RemedyBio offers products and services including Therapeutic Discovery Platform and Immune System Mapping Tool. RemedyBio operates in a competitive market with competitors including Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.43 M (USD)
in 4 rounds
-
Latest Funding Round
$22.91 K (USD), Grant
Jun 01, 2022
-
Investors
Enterprise Ireland
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RemedyBio
RemedyBio offers a comprehensive portfolio of products and services, including Therapeutic Discovery Platform and Immune System Mapping Tool.
Platform for mapping cell functions to discover new immune therapies.
Tool that analyzes patient biology for therapeutic development.
Funding Insights of RemedyBio
RemedyBio has successfully raised a total of $9.43M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $22.91 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RemedyBio
RemedyBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Enterprise Ireland, European Union and Dublin City University.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Locked | Locked | Locked |
Investor details for RemedyBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RemedyBio
Investment portfolio details for RemedyBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RemedyBio
Detailed financials for RemedyBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remedybio Comparisons
Peer comparison for RemedyBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RemedyBio
RemedyBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Syndax, Abingdon Health, Clovis Oncology and Spear Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Targeted therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Develops innovative immunotherapy drugs for cancer treatment.
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Developer of cancer therapeutics for the treatment of blood cancer
|
Detailed competitors of RemedyBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remedybio
Complete news archive for RemedyBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RemedyBio
RemedyBio was founded in 2017 and raised its 1st funding round 3 years after it was founded.
RemedyBio is headquartered in Dublin, Ireland.
RemedyBio is a funded company, having raised a total of $9.43M across 4 funding rounds to date.
RemedyBio was founded in 2017 in Dublin, Ireland, within the biotechnology sector. Personalized, cell-based, and autologous therapies targeting tumors are developed and offered. Nanoscale biotechnology is employed for diagnostic purposes in immunoncology, autoimmune diseases, and infectious conditions. Individual cell functions are analyzed across 10 million to 1 billion living cells to support therapeutic design and evaluation.
RemedyBio's top competitors include Syndax, Annexon and Abingdon Health.
RemedyBio offers Therapeutic Discovery Platform and Immune System Mapping Tool.
RemedyBio has 5 investors. Key investors include Enterprise Ireland, European Union, Dublin City University, Science Foundation Ireland, and EIC Fund.